Melanoma: Even occasional sunburn can be harmful

January 27, 2025

Oncologists urge skin cancer screening and prevention

This SunSmart Skin Cancer Awareness Month, two clinical oncologists practising at Netcare Alberton Hospital highlight the importance of sun protection and regular screening in South Africa’s sunny climate, focusing on melanoma awareness.

 

Skin cancer is the most common type of cancer in South Africa. The main types of skin cancer are squamous cell carcinoma, basal cell carcinoma and melanoma.

 

“It’s been estimated that South Africa receives 2 500 hours of sunshine on average a year, and being an outdoors-loving nation this unfortunately comes with heightened risk of skin cancer,” says Dr Sylvia Rodrigues.

 

“Although not all skin cancers are attributable to sun exposure, even occasional sunburn can increase a person’s risk for developing these types of cancer.”

 

The skin is the body's largest organ. It protects against heat, sunlight, injury and infection. The skin has several layers, but the two main layers are the epidermis (the top or outer layer) and the dermis (the lower or inner layer). Skin cancer begins in the epidermis, which is made up of three kinds of cells: squamous cells, basal cells and melanocytes. 

Certain types of skin cancer can spread to other parts of the body and have potentially severe effects if they remain undiagnosed and untreated, warns clinical oncologist Dr Karen Motilall, who is pictured with Netcare Alberton Hospital radiation therapy unit manager Busi Mzelem.

Clinical oncologist Dr Karen Motilall with Netcare Alberton Hospital radiation therapy unit manager Busi Mzelem.

“Cancers that originate in the cells of the skin are known as skin cancers, although some types can spread to other parts of the body and have potentially severe effects if they remain undiagnosed and untreated,” says Dr Karen Motilall.

 

“Melanoma, which originates in the melanocytes or pigment-producing skin cells, is often regarded as the most dreaded form of skin cancer because of how quickly it can spread, or metastasise. Although exposure to the sun’s ultraviolet rays has a role in skin cancer, melanoma in particular is associated with a strong genetic or family risk – although this may not always be present,” she explains.

 

Melanoma often looks like a mole or a new growth on the skin with an uneven form. It might be dark or light, presenting in various colours from skin tone, pink, red, black, purple, blue, or white. The mole or lesion may also be multicoloured and could have an asymmetrical shape. Other signs to watch for include a mole that scales, oozes, bleeds, itches or other changes in sensation or appearance.

 

Dr Rodrigues points out that while people with fairer skin are generally more prone to melanoma, those with darker skin are at higher risk of acral lentiginous melanoma (ALM), an especially aggressive form of melanoma that usually appears as a mark on the palms of the hands or soles of the feet, or under a nail.

 

“The key is not to wait if you notice a new mark on your skin or a change in one of your moles – rather book an appointment with your GP or dermatologist as soon as possible before it can spread. Better yet, make regular mole mapping part of your annual health routine for peace of mind,” Dr Rodrigues advises.

 

“Although there is more we can do to treat and manage various kinds of skin cancer, prevention must always be the main priority. Protect yourself and your children from sun exposure, and discuss your individual risk for skin cancer, which may include family history and conditions such as albinism, with your healthcare practitioner, who can advise and monitor you more closely if needed.”

 

The integrated cancer care centre within Netcare Alberton Hospital offers a comprehensive diagnosis and treatment service, including surgery, chemotherapy and radiation therapy. An experienced multidisciplinary team provides professional, holistic care for each person’s individual needs.

 

“Depending on the type and stage of skin cancer diagnosed, we may recommend surgery, chemotherapy or radiotherapy, or a combination of these options to remove and reduce the cancerous cells both at the primary site and elsewhere if it has started to affect lymph nodes or other organs,” Dr Karen Motilall says.

 

“Given melanoma’s tendency to metastasise, radiation therapy is showing more promise for treating the spread of skin cancer cells within the body, described as stage four cancer. Using the Varian TrueBeam™ 4.0 linear accelerator, we are able to target the metastases with great accuracy, wherever they may be in the body, sparing nearby nerves, healthy tissue and critical structures from the effects of radiation,” she says.

 

“As oncologists, we really would like to encourage everyone to take steps to prevent skin cancer as far as possible, and protect themselves and their families against the harmful effects of sun exposure. As one of the most common types of cancer in our country, we need the power of public awareness to help improve outcomes and survival rates.”

Paediatric Nephrologist Prof Rajendra Bhimma
March 11, 2025
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Prof Bhekifa Dube
March 7, 2025
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
Rare Disease Day on 28 February 2025
February 28, 2025
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr Barbara Makumbi explains the toll acid reflux can take on your health
February 26, 2025
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
Netcare St Anne’s Hospital emergency department now has both trauma and emergency  specialists.
February 19, 2025
From treating trauma injuries caused by wildlife, road accidents and sports, to heart attacks, stroke, or the sudden onset of other concerning medical symptoms – the emergency department at Netcare St Anne’s Hospital never sleeps.
Making sense of self-harm
February 10, 2025
As many as one in ten teenagers may self-harm, often in secret, concealing the scars or evidence of their injuries. As Teen Suicide Prevention Week approaches, Netcare Akeso is highlighting the often-hidden struggle of self-harm among young people.
Dr Prinitha Pillay is a radiation and clinical oncologist
February 4, 2025
With one in four South Africans affected by cancer, either directly or through a loved one’s diagnosis, the importance of regular screenings cannot be overstated.
Vitamin D is crucial for maintaining strong bones and a healthy immune system.
January 17, 2025
Vitamin D is crucial for maintaining strong bones and a healthy immune system. Dr Jay Narainsamy, an endocrinologist and specialist physician, explains why too much can negatively impact your health.
Dr Neville Vlok highlights health issues that could disrupt holiday celebrations
December 22, 2024
As the holiday season kicks off, it’s all too easy to get caught up in the festive spirit and overlook potential medical emergencies. Dr Neville Vlok, a specialist emergency medicine physician practising in the emergency department at Netcare Unitas Hospital, highlights four health issues that could disrupt even the most carefully planned holiday celebrations.
Radiology concept
December 11, 2024
Clinical oncologists Dr Sylvia Rodrigues and Dr Karen Motilall have been prescribing radiation treatments for their cancer patients requiring this treatment modality, with the Varian TrueBeam™ 4.0 linear accelerator (linac), for the past year and have seen the equipment’s versatility and advantages for patients.
More Posts
Share by: